Intravascular Lymphoma Presenting as Telangectasias: Response to Rituximab and Combination Chemotherapy

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 6, 2003, Pages 460-463

  Weichert, Gabriele ^a   Martinka, Magdalena ^a   Rivers, Jason K ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Division of Dermatology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GABAPENTIN; METHOTREXATE; MISOPROSTOL; MONOCLONAL ANTIBODY; PENTOXIFYLLINE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CASE REPORT; DRUG EFFICACY; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; PAIN; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; TELANGIECTASIA; TREATMENT OUTCOME; VASCULAR TUMOR;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; DRUG THERAPY, COMBINATION; HUMANS; LEG; LYMPHOMA, B-CELL; MALE; PREDNISONE; TELANGIECTASIS; VINCRISTINE;

EID: 1242285106     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-003-0153-6     Document Type: Review

References (24)

1. Lopez-Gil F, Roura M, Umbert I, et al. Malignant proliferative angioendotheliomatosis or angiotropic lymphoma associated with a soft-tissue lymphoma. J Am Acad Dermatol 1992; 26:101-104.
2. Kraus M, Jones D, Bartlett N. Intravascular lymphoma associated with endocrine dysfunction: A report of four cases and a review of the literature. Am J Med 1999; 107:169-176.
3. Berger TG, Dawson NA. Angioendotheliomatosis. J Am Acad Dermatol 1988; 18:407-412.
4. Demirer T, Dail DH, Aboulafia DM. Four cases of intravascular lymphomatous and a literature review. Cancer 1994; 3:1738-1745.
5. Domizio P, Hall PA, Cotter F, et al. Large cell lymphoma (ALCL): morphological and genotype studies with analysis of previous reports. Hematol Oncol 1989; 7:195-206.
6. Thyss A. Rituximab: a major role in treatment of malignant B lymphoid proliferations. Cancer Futures 2002; 1:80-84.
7. Paul T, Radny P, Krober SM, et al. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol 2001; 144:1239-1243.
8. Bonnekoh B, Schulz M, Franke I, et al. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab. J Can Res Clin Oncol 2002; 128:161-166.
9. Requena L, Sanguenza OP. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplams. J Am Acad Dermatol 1998; 38:143-175.
10. Wilson B. Indurated telangiectatic plaques. Arch Dermatol 1992; 128:255.
11. Keahey TM, Guerry D, Tuthill RJ, et al. Malignant angioendotheliomatosis proliferans treated with doxorubicin. Arch Dermatol 1982; 118:512-514.
12. Ozguroglu E, Buyulbabani N, Ozguroglu M, et al. Generalized telangectasia as the major manifestation of (intravascular) lymphoma. Br J Dermatol 1997; 137:422-425.
13. Chang A, Zic JA, Boyd AS. Intravascular large cell lymphoma: a patient with asymptomatic purpuric patches and a chronic clinical course. J Am Acad Dermatol 1998; 39:318-322.
14. Kiyohara T, Kumakira M, Kobayashi H, et al. A case of intravascular large B-cell lymphoma mimiking erythema nodosum: the importance of multiple skin biopsies. J Cutan Pathol 2000; 27:413-418.
15. Glass J, Hockberg FH, Miller DC. Intravascular lymphomatosis. A systemic disease with neurological manifestations. Cancer 1993; 71:3156-3164.
16. Willhemze R, Keri H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 1:354-371.
17. DiGiuseppe JA, Nelson WG, Siefer EJ, et al. Intravascular lymphomatosis: a clinicopathological study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994; 12:2573-2579.
18. Perniciaro C, Winkelman RK, Daoud MS, et al. Malignant angioendotheliomatosis and angiotrophic intravascular lymphoma. Am J Dermatopathol 1995; 17:242-248.
19. Nakahara T, Saito T, Sugiura Y, et al. Intravascular lymphomatosis presenting as ascending cauda equina: remission after biweekly CHOP therapy. J Neurol Neurosurg Psychiatry 1999; 67:403-406.
20. Walls JG, Hong YG, Cox JE, et al. Pulmonary intravascular lymphomatosis: presentation with dyspnea and air trapping. Chest 1999; 115:1207-1210.
21. Baumann TP, Hurwitz N, Karamitopolou-Diamantis E, et al. Diagnsosis and treatment of intravascular lymphomatosis. Arch Neurol 2000; 57:374-377.
22. Massimino M, Giardini R, Cefalo G, et al. Intravascular lymphomatosis in a child mimicking a posterior fossa tumour. J Neurooncol 2001; 51:47-50.
23. Calamia KT, Miller A, Shuster EA, et al. Intravascular lymphomatosis. A report of ten patients with central nervous system involvement and review of disease process. Adv Exp Med Biol 1999; 455:249-265.
24. Adachi H, Tsuboi M, Hayashi K. Intravascular lymphomatosis: a case report. No Shinkei 2001; 29:659-665.